The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for EURneffy, an adrenaline ...

A new emergency treatment for allergic reactions will now be available in the UK – in the form of a nasal spray. The first needle-free emergency treatment for anaphylaxis – in the form of a nasal ...

These are the benefits and side effects of viral nano-hydroxyapatite toothpastes like NOBS, as well as why dentists recommend ...

Vitamin B12 supplements might be recommended to people who are at particular risk of being deficient in it. This includes ...

The symptoms of dry eye are multifactorial, says Mina Massaro-Giordano, MD, making identifying and treating dry eye important ...

Calling upon all relevant stakeholders to position local pharmaceutical manufacturing as a ‘thrust industry’ which can reduce ...

It is estimated that one in three children has an allergic condition, making paediatric allergies a common presentation in ...

Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...

Intranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...

The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

Inside Information ALK (ALKB:DC / OMX: ALK B) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved EURneffy® 2 mg in the United Kingdom (UK) for anaphylaxis ...